Latest Headlines

  1. Cepheid To Unveil Third-Generation GeneXpert® System At ADLM 2026, Advancing Molecular Diagnostic Capabilities 7/22/2026

    Cepheid, a Danaher company, and a leader in molecular diagnostics, will unveil the third generation of the GeneXpert system at the Association for Diagnostics & Laboratory Medicine (ADLM) Annual Scientific Meeting in a special booth presentation on Tuesday, July 28.

  2. Roche Showcases Intelligent Lab Solutions And High-Precision Instruments At ADLM 2026 To Help Laboratories Address Workforce And Workflow Challenges 7/22/2026
  3. Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies In India For Tuberculosis Test On PCR Platform 7/22/2026

    Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that CoSara Diagnostics Pvt. Ltd. ("CoSara"), the Company's joint venture in India, is initiating clinical studies for the tuberculosis test on the CoSara PCR Pro® instrument.

  4. Steps Taken To Enhance National Preparedness Against Emerging Infectious Diseases 7/21/2026

    The Union Health Ministry regularly reviews and strengthens its preparedness for the detection and response to emerging infectious diseases through various national programs and institutions including the Viral Research and Diagnostic Laboratories (VRDL) network, genomic surveillance initiatives and wastewater surveillance for early detection of pathogens of public health importance. The preparedness is further strengthened through participation in simulation exercises, mock drills and rapid outbreak response mechanisms.

  5. Seek Labs Announces Publication In Nature Communications Validating ANINA™, A Room-Temperature, Instrument-Free Amplification Diagnostic Technology Designed To Deliver PCR-Level Sensitivity At The Point Of Need 7/21/2026

    Seek Labs, a private TechBio company building programmable platforms to decode, program, and resolve diseases, announced the publication of a peer-reviewed manuscript in Nature Communications describing Annexing Isothermal Nucleotide Amplification (ANINA), the proprietary amplification chemistry that powers its SeekIt molecular diagnostic platform.

  6. OraSure Receives Emergency Use Authorization For Second Generation Ebola Test 7/21/2026

    OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its second generation OraQuick™ Ebola 2.0 Rapid Antigen Test for use with whole blood in live patients, as well as cadaveric oral fluid from individuals suspected to have had Ebola disease at the time of death.

  7. SYNLAB And Microba Advance Partnership With Latest-Generation Microbiome Testing 7/20/2026

    SYNLAB, a leader in medical diagnostic services and specialty testing in Europe, and Microba Life Sciences have entered into a new three-year agreement to advance their partnership in microbiome diagnostics across selected markets in Europe and Latin America.

  8. Umbrella Lab Announces Documentation And Traceability Update For YK-11 Reference Material 7/17/2026

    Umbrella Labs today issued a company announcement confirming an internal documentation and traceability update for YK-11 reference material, provided strictly for laboratory developmental research use only.

  9. Devyser Announced The Launch Of Next Generation Chimerism Analysis Solution, Strengthening Its Offering In Post-Transplant Monitoring 7/16/2026

    One Lambda Devyser Chimerism Plus is a next generation solution for chimerism analysis following allogeneic hematopoietic stem cell transplantation (HSCT). Building on the proven performance of the existing assay for chimerism monitoring, this assay features an innovative assay design that reduces the risk of errors associated with complex testing workflows while improving laboratory efficiency and ease of use.

  10. LigoLab Partners With MarginLogic Health AI To Deliver AI-Powered OCR For Laboratories 7/16/2026

    LigoLab, a leading provider of unified laboratory information systems and laboratory revenue cycle management solutions, today announced a marketplace agreement with MarginLogic Health AI, a healthcare technology company specializing in AI-powered optical character recognition (OCR), intelligent document processing, and workflow automation.